Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia

Brain Research Reviews

Volumn 59, Issue 1, 2008, Pages 22-33

  van der Kooij, Michael A ^a   Groenendaal, Floris ^a   Kavelaars, Annemieke ^a   Heijnen, Cobi J ^a   van Bel, Frank ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Erythropoietin; Hypoxia; Ischemia; Mechanism; Neuroprotection; Review

Indexed keywords

ASIALO ERYTHROPOIETIN; CARBAMYLATE ERYTHTROPOIETIN; CYTOCHROME C; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; RAF PROTEIN; RECOMBINANT ERYTHROPOIETIN; STAT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BINDING SITE; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; REGENERATION; REVASCULARIZATION; REVIEW; STROKE;

ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 53749093232     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.04.007     Document Type: Review

References (105)

1. Banks W.A., Jumbe N.L., Farrell C.L., Niehoff M.L., and Heatherington A.C. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur. J. Pharmacol. 505 (2004) 93-101
2. Belayev L., Khoutorova L., Zhao W., Vigdorchik A., Belayev A., Busto R., Magal E., and Ginsberg M.D. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke 36 (2005) 1071-1076
3. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., and Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19 (1999) 643-651
4. Bernaudin M., Bellail A., Marti H.H., Yvon A., Vivien D., Duchatelle I., MacKenzie E.T., and Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30 (2000) 271-278
5. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., and Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22 (2002) 393-403
6. Bhat R.V., Shanley J., Correll M.P., Fieles W.E., Keith R.A., Scott C.W., and Lee C.M. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11074-11079
7. Bhat R.V., Budd Haeberlein S.L., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317
8. Blake T.J., Jenkins B.J., D'Andrea R.J., and Gonda T.J. Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor. J. Leukoc. Biol. 72 (2002) 1246-1255
9. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6 (2005) 484-494
10. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10526-10531
11. Brines M., Grasso G., Fiordaliso F., Sfacteria A., Ghezzi P., Fratelli M., Latini R., Xie Q.W., Smart J., Su-Rick C.J., Pobre E., Diaz D., Gomez D., Hand C., Coleman T., and Cerami A. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A 101 (2004) 14907-14912
12. Byts N., Samoylenko A., Fasshauer T., Ivanisevic M., Hennighausen L., Ehrenreich H., and Sirén A.L. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death. Differ. 15 (2008) 783-792
13. Calapai G., Marciano M.C., Corica F., Allegra A., Parisi A., Frisina N., Caputi A.P., and Buemi M. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401 (2000) 349-356
14. Carnot P., and Deflandre C. S'ur l'activite hematopoietique de serum au cours de la regeneration du sang. C. R. Acad. Sci. 143 (1906) 384-386
15. Casadevall N., Nataf J., Viron B., Kolta A., Kiladjian J.J., Martin-Dupont P., Michaud P., Papo T., Ugo V., Teyssandier I., Varet B., and Mayeux P. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med. 346 (2002) 469-475
16. Chang Y.S., Mu D., Wendland M., Sheldon R.A., Vexler Z.S., McQuillen P.S., and Ferriero D.M. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr. Res. 58 (2005) 106-111
17. Chin K., Yu X., Beleslin-Cokic B., Liu C., Shen K., Mohrenweiser H.W., and Noguchi C.T. Production and processing of erythropoietin receptor transcripts in brain. Brain Res. Mol. Brain Res. 81 (2000) 29-42
18. Chong Z.Z., Kang J.Q., and Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106 (2002) 2973-2979
19. Chong Z.Z., Kang J.Q., and Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br. J. Pharmacol. 138 (2003) 1107-1118
20. Coleman T.R., Westenfelder C., Togel F.E., Yang Y., Hu Z., Swenson L., Leuvenink H.G., Ploeg R.J., d'Uscio L.V., Katusic Z.S., Ghezzi P., Zanetti A., Kaushansky K., Fox N.E., Cerami A., and Brines M. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5965-5970
21. Culmsee C., and Mattson M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331 (2005) 761-777
22. D'Andrea R.J., and Gonda T.J. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit. Exp. Hematol. 28 (2000) 231-243
23. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
24. Debierre-Grockiego F. Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies. Apoptosis. 9 (2004) 717-728
25. Demers E.J., McPherson R.J., and Juul S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr. Res. 58 (2005) 297-301
26. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412 (2001) 641-647
27. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., and Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3717-3720
28. Ehrenreich H. Medicine. A boost for translational neuroscience. Science 305 (2004) 184-185
29. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De R.M., Itri L., Prange H., Cerami A., Brines M., and Sirén A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8 (2002) 495-505
30. Erbayraktar S., Grasso G., Sfacteria A., Xie Q.W., Coleman T., Kreilgaard M., Torup L., Sager T., Erbayraktar Z., Gokmen N., Yilmaz O., Ghezzi P., Villa P., Fratelli M., Casagrande S., Leist M., Helboe L., Gerwien J., Christensen S., Geist M.A., Pedersen L.O., Cerami-Hand C., Wuerth J.P., Cerami A., and Brines M. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6741-6746
31. Felderhoff-Mueser U., Taylor D.L., Greenwood K., Kozma M., Stibenz D., Joashi U.C., Edwards A.D., and Mehmet H. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol. 10 (2000) 17-29
32. Gonzalez F.F., McQuillen P., Mu D., Chang Y., Wendland M., Vexler Z., and Ferriero D.M. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 29 (2007) 321-330
33. Iwai M., Cao G., Yin W., Stetler R.A., Liu J., and Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 38 (2007) 2795-2803
34. Jones N.M., and Bergeron M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cereb. Blood Flow Metab. 21 (2001) 1105-1114
35. Jubinsky P.T., Krijanovski O.I., Nathan D.G., Tavernier J., and Sieff C.A. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90 (1997) 1867-1873
36. Juul S.E., McPherson R.J., Bammler T.K., Wilkerson J., Beyer R.P., and Farin F.M. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev. Neurosci. 30 (2007) 231-242
37. Kane L.P., Shapiro V.S., Stokoe D., and Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9 (1999) 601-604
38. Kawakami M., Iwasaki S., Sato K., and Takahashi M. Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells. Biochem. Biophys. Res. Commun. 279 (2000) 293-297
39. Kawakami M., Sekiguchi M., Sato K., Kozaki S., and Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276 (2001) 39469-39475
40. Keller M., Yang J., Griesmaier E., Gorna A., Sarkozy G., Urbanek M., Gressens P., and Simbruner G. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol. Dis. 24 (2006) 357-366
41. Kellert B.A., McPherson R.J., and Juul S.E. A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr. Res. 61 (2007) 451-455
42. Kilic E., Kilic U., Soliz J., Bassetti C.L., Gassmann M., and Hermann D.M. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 19 (2005) 2026-2028
43. Konishi Y., Chui D.H., Hirose H., Kunishita T., and Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609 (1993) 29-35
44. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., and Kato Y. Effects of erythropoietin on neuronal activity. J. Neurochem. 72 (1999) 2565-2572
45. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., Ulukus C., Genc S., and Ozkan H. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate 83 (2003) 224-228
46. Kumral A., Uysal N., Tugyan K., Sonmez A., Yilmaz O., Gokmen N., Kiray M., Genc S., Duman N., Koroglu T.F., Ozkan H., and Genc K. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav. Brain Res. 153 (2004) 77-86
47. Lee S.T., Chu K., Sinn D.I., Jung K.H., Kim E.H., Kim S.J., Kim J.M., Ko S.Y., Kim M., and Roh J.K. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J. Neurochem. 96 (2006) 1728-1739
48. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., Savino C., Bianchi M., Nielsen J., Gerwien J., Kallunki P., Larsen A.K., Helboe L., Christensen S., Pedersen L.O., Nielsen M., Torup L., Sager T., Sfacteria A., Erbayraktar S., Erbayraktar Z., Gokmen N., Yilmaz O., Cerami-Hand C., Xie Q.W., Coleman T., Cerami A., and Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
49. Lewczuk P., Hasselblatt M., Kamrowski-Kruck H., Heyer A., Unzicker C., Sirén A.L., and Ehrenreich H. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 11 (2000) 3485-3488
50. Li Y., Lu Z., Keogh C.L., Yu S.P., and Wei L. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood Flow Metab. 27 (2007) 1043-1054
51. Li Y., Lu Z.Y., Ogle M., and Wei L. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Neurochem. Res. 32 (2007) 2132-2141
52. Lin Y., and Benchimol S. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol. Cell Biol. 15 (1995) 6045-6054
53. Malhotra S., Savitz S.I., Ocava L., and Rosenbaum D.M. Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J. Neurosci. Res. 83 (2006) 19-27
54. Marti H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., and Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8 (1996) 666-676
55. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas Jr. F., Tabira T., and Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 268 (1993) 11208-11216
56. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., and Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269 (1994) 19488-19493
57. Matsushita H., Johnston M.V., Lange M.S., and Wilson M.A. Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 14 (2003) 1757-1761
58. McClure M.M., Threlkeld S.W., and Fitch R.H. The effects of erythropoietin on auditory processing following neonatal hypoxic-ischemic injury. Brain Res. 1087 (2006) 190-195
59. McPherson R.J., Demers E.J., and Juul S.E. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology. 91 (2007) 36-43
60. Meloni B.P., Tilbrook P.A., Boulos S., Arthur P.G., and Knuckey N.W. Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J. Neurosci. Res. 83 (2006) 584-593
61. Montero M., Poulsen F.R., Noraberg J., Kirkeby A., van B.J., Leist M., and Zimmer J. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp. Neurol. 204 (2007) 106-117
62. Morishita E., Narita H., Nishida M., Kawashima N., Yamagishi K., Masuda S., Nagao M., Hatta H., and Sasaki R. Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells. Blood 88 (1996) 465-471
63. Nagai A., Nakagawa E., Choi H.B., Hatori K., Kobayashi S., and Kim S.U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60 (2001) 386-392
64. Nakagawa T., Suga S., Kawase T., and Toda M. Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model. Brain Res. 1089 (2006) 179-185
65. Nijboer C.H., Groenendaal F., Kavelaars A., Hagberg H.H., van Bel F., and Heijnen C.J. Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J. Cereb. Blood Flow Metab. 27 (2007) 282-292
66. Noguchi C.T., Asavaritikrai P., Teng R., and Jia Y. Role of erythropoietin in the brain. Crit Rev. Oncol. Hematol. 64 (2007) 159-171
67. Prass K., Ruscher K., Karsch M., Isaev N., Megow D., Priller J., Scharff A., Dirnagl U., and Meisel A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22 (2002) 520-525
68. Rice III J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9 (1981) 131-141
69. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
70. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S., and Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253 (1998) 26-32
71. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4635-4640
72. Schäbitz W.R., Kruger C., Pitzer C., Weber D., Laage R., Gassler N., Aronowski J., Mier W., Kirsch F., Dittgen T., Bach A., Sommer C., and Schneider A. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 28 (2007) 29-43
73. Scott C.L., Robb L., Papaevangeliou B., Mansfield R., Nicola N.A., and Begley C.G. Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor. Blood 96 (2000) 1588-1590
74. Shang Y., Wu Y., Yao S., Wang X., Feng D., and Yang W. Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: involvement of PI3K/Akt and GSK-3 beta pathway. Apoptosis. 12 (2007) 2187-2195
75. Sharp F.R., Ran R., Lu A., Tang Y., Strauss K.I., Glass T., Ardizzone T., and Bernaudin M. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx. 1 (2004) 26-35
76. Sharp F.R., Ran R., Lu A., Tang Y., Strauss K.I., Glass T., Ardizzone T., and Bernaudin M. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx. 1 (2004) 26-35
77. Shingo T., Sorokan S.T., Shimazaki T., and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21 (2001) 9733-9743
78. Sirén A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4044-4049
79. Socolovsky M., Fallon A.E., Wang S., Brugnara C., and Lodish H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98 (1999) 181-191
80. Socolovsky M., Nam H., Fleming M.D., Haase V.H., Brugnara C., and Lodish H.F. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98 (2001) 3261-3273
81. Sola A., Rogido M., Lee B.H., Genetta T., and Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr. Res. 57 (2005) 481-487
82. Sola A., Wen T.C., Hamrick S.E., and Ferriero D.M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr. Res. 57 (2005) 110R-117R
83. Spandou E., Papoutsopoulou S., Soubasi V., Karkavelas G., Simeonidou C., Kremenopoulos G., and Guiba-Tziampiri O. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res. 1021 (2004) 167-172
84. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., and Guiba-Tziampiri O. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 1045 (2005) 22-30
85. Sugawa M., Sakurai Y., Ishikawa-Ieda Y., Suzuki H., and Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44 (2002) 391-403
86. Sun Y., Zhou C., Polk P., Nanda A., and Zhang J.H. Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J. Cereb. Blood Flow Metab. 24 (2004) 259-270
87. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 (2005) 1672-1678
88. Tsai P.T., Ohab J.J., Kertesz N., Groszer M., Matter C., Gao J., Liu X., Wu H., and Carmichael S.T. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J. Neurosci. 26 (2006) 1269-1274
89. Um M., Gross A.W., and Lodish H.F. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal. 19 (2007) 634-645
90. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., and Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198 (2003) 971-975
91. Villa P., van B.J., Larsen A.K., Gerwien J., Christensen S., Cerami A., Brines M., Leist M., Ghezzi P., and Torup L. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J. Cereb. Blood Flow Metab. 27 (2007) 552-563
92. Wang X., Zhu C., Qiu L., Hagberg H., Sandberg M., and Blomgren K. Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J. Neurochem. 86 (2003) 351-362
93. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
94. Wang L., Zhang Z., Zhang R., Hafner M.S., Wong H.K., Jiao Z., and Chopp M. Erythropoietin up-regulates SOCS2 in neuronal progenitor cells derived from SVZ of adult rat. Neuroreport 15 (2004) 1225-1229
95. Wang X., Zhu C., Wang X., Gerwien J.G., Schrattenholz A., Sandberg M., Leist M., and Blomgren K. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J. Neurochem. 91 (2004) 900-910
96. Wang Y., Zhang Z.G., Rhodes K., Renzi M., Zhang R.L., Kapke A., Lu M., Pool C., Heavner G., and Chopp M. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br. J. Pharmacol. 151 (2007) 1377-1384
97. Wei L., Han B.H., Li Y., Keogh C.L., Holtzman D.M., and Yu S.P. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J. Pharmacol. Exp. Ther. 317 (2006) 109-116
98. Wen T.C., Sadamoto Y., Tanaka J., Zhu P.X., Nakata K., Ma Y.J., Hata R., and Sakanaka M. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res. 67 (2002) 795-803
99. Wen T.C., Rogido M., Peng H., Genetta T., Moore J., and Sola A. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 139 (2006) 803-811
100. Wu Y., Shang Y., Sun S., Liang H., and Liu R. Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis. 12 (2007) 1365-1375
101. Wu Y., Shang Y., Sun S., and Liu R. Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur. J. Pharmacol. 564 (2007) 47-56
102. Yamaji R., Okada T., Moriya M., Naito M., Tsuruo T., Miyatake K., and Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239 (1996) 494-500
103. Yu Y.P., Xu Q.Q., Zhang Q., Zhang W.P., Zhang L.H., and Wei E.Q. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci. Lett. 387 (2005) 5-10
104. Zhang F., Signore A.P., Zhou Z., Wang S., Cao G., and Chen J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J. Neurosci. Res. 83 (2006) 1241-1251
105. Zhang F., Wang S., Cao G., Gao Y., and Chen J. Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia. Neurobiol. Dis. 25 (2007) 45-53